Publications by authors named "Salomon Manier"

59Publications

Genome instability in multiple myeloma.

Leukemia 2020 Nov 10;34(11):2887-2897. Epub 2020 Jul 10.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-020-0921-yDOI Listing
November 2020

On the road to molecular prognostication in SMM.

Authors:
Salomon Manier

Leukemia 2020 02 12;34(2):331-332. Epub 2019 Nov 12.

Department of Hematology, CHU Lille, University of Lille, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0627-1DOI Listing
February 2020

[Multiple myeloma: New criteria for diagnosis and treatment, strong therapeutic hopes].

Presse Med 2019 Jul - Aug;48(7-8 Pt 1):825-831. Epub 2019 Aug 22.

CHU de Lille, hôpital Huriez, université de Lille, service d'hématologie, 59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2019.07.023DOI Listing
September 2019

Immunotherapy in Multiple Myeloma: Accelerating on the Path to the Patient.

Clin Lymphoma Myeloma Leuk 2019 06 20;19(6):332-344. Epub 2019 Feb 20.

Winship Cancer Institute of Emory University, Atlanta, GA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.02.004DOI Listing
June 2019

Antigen excess pitfall for free light chains measurements solved by ELISA assay.

Am J Hematol 2019 05 6;94(5):E120-E122. Epub 2019 Feb 6.

Biochemistry and Molecular Biology Department, University of Lille CHU, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25422DOI Listing
May 2019

[Circulating exosomal microRNA as biomarkers in mutiple myeloma].

Med Sci (Paris) 2017 Nov 4;33(11):939-941. Epub 2017 Dec 4.

Institut universitaire du cancer Oncopole, avenue Hubert Curien, 31100 Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/20173311008DOI Listing
November 2017

Exosomes in Tumor Angiogenesis.

Methods Mol Biol 2016 ;1464:25-34

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-3999-2_3DOI Listing
January 2018

Genomic complexity of multiple myeloma and its clinical implications.

Nat Rev Clin Oncol 2017 02 17;14(2):100-113. Epub 2016 Aug 17.

Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, HIM 237, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.122DOI Listing
February 2017

Epigenetics in Multiple Myeloma.

Cancer Treat Res 2016;169:35-49

Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-40320-5_4DOI Listing
June 2017

Genomic Aberrations in Multiple Myeloma.

Cancer Treat Res 2016;169:23-34

Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-40320-5_3DOI Listing
June 2017

Future Directions in the Evaluation and Treatment of Precursor Plasma Cell Disorders.

Am Soc Clin Oncol Educ Book 2016 ;35:e400-6

From the Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_159010DOI Listing
January 2017

Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma.

Curr Opin Hematol 2016 07;23(4):426-33

aMedical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA *Aldo M. Roccaro and Irene M. Ghobrial are co-senior authors.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000259DOI Listing
July 2016

The cancer glycome: carbohydrates as mediators of metastasis.

Blood Rev 2015 Jul 23;29(4):269-79. Epub 2015 Jan 23.

Glycoscience Research Group, National University of Ireland, Galway, Ireland; Department of Hematology National University of Ireland, Galway and Galway University Hospital, Ireland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2015.01.003DOI Listing
July 2015

Targeting the bone marrow microenvironment in multiple myeloma.

Immunol Rev 2015 Jan;263(1):160-72

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imr.12233DOI Listing
January 2015

Global epigenetic regulation of microRNAs in multiple myeloma.

PLoS One 2014 17;9(10):e110973. Epub 2014 Oct 17.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0110973PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201574PMC
December 2015

The role of miRNAs in plasma cell dyscrasias.

Microrna 2014 ;2(3):165-73

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/2211536602666131126002144DOI Listing
April 2018

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma.

Blood 2014 Sep 24;124(11):1765-76. Epub 2014 Jul 24.

Department of Hematology, National University of Ireland, Galway and Galway University Hospital, Galway, Ireland; Glycoscience Research Group, National University of Ireland, Galway, Ireland.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2014-03-56
Publisher Site
http://dx.doi.org/10.1182/blood-2014-03-560862DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162107PMC
September 2014

Role of endothelial progenitor cells in cancer progression.

Biochim Biophys Acta 2014 Aug 4;1846(1):26-39. Epub 2014 Apr 4.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbcan.2014.03.005DOI Listing
August 2014

Regulation of microRNAs in cancer metastasis.

Biochim Biophys Acta 2014 Apr 22;1845(2):255-65. Epub 2014 Feb 22.

Dana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, 450 Brookline Avenue, HIM 246, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbcan.2014.02.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170185PMC
April 2014

microRNA aberrations in Waldenström macroglobulinemia.

Clin Lymphoma Myeloma Leuk 2013 Apr 7;13(2):205-7. Epub 2013 Mar 7.

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.02.007DOI Listing
April 2013

Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosis.

Expert Rev Hematol 2012 Dec;5(6):617-26; quiz 627

Service des Maladies du Sang, Hôpital Huriez, CHRU, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.12.52DOI Listing
December 2012

Mechanisms of activity of the TORC1 inhibitor everolimus in Waldenstrom macroglobulinemia.

Clin Cancer Res 2012 Dec 9;18(24):6609-22. Epub 2012 Oct 9.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-1532DOI Listing
December 2012